Examination of Setarud (IMOD™) in the management of patients with severe sepsis

BACKGROUND AND THE PURPOSE OF THE STUDY: Analysis of current immunomodulating strategies indicates that monovalent approaches are unlikely to restore immunostasis or achieve complete therapy of sepsis. Setarud (IMOD) as a mixture of urtica, carotenoids, urea, and selenium has been recently patented...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Mahmoodpoor, A., Eslami, K., Mojtahedzadeh, M., Najafi, A., Ahmadi, A., Dehnadi-Moghadam, A., Mohammadirad, A., Baeeri, M., Abdollahi, M.
格式: Artigo
語言:Inglês
出版: Tehran University of Medical Sciences 2010
主題:
Original Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3232081/
https://ncbi.nlm.nih.gov/pubmed/22615589
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍